Laser procedure for female urinary stress incontinence: A review of the literature

Conté, C.; Jauffret, T.; Vieillefosse, Sarah; Hermieu, J.-F.; Deffieux, X.

doi:10.1016/j.purol.2017.09.003

Cited by 21 publications

(8 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present study, a significant reduction in the total ICIQ‐UI SF score was observed only in the laser CO 2 group ( P = 0.004). Our results agree with those of other studies that reported reductions in total ICIQ‐UI SF scores in women with mild to moderate urinary incontinence [17,25,26]. A systematic review that involved 13 studies, most of which were observational, case–control or case reports, showed that laser therapy can provide a useful and minimally invasive approach.…”

Section: Discussionsupporting

confidence: 91%

“…Perino et al [5] observed in a non‐randomized study, with few subjects, that the CO 2 laser could be effective for treating OAB symptoms because of the improvement in atrophy of the urethral and bladder mucosa. Laser therapy thermal effects may promote remodeling and production of new collagen fibers, stimulate elastin formation, and modulate the metalloproteinases activation at molecular level, which is fundamental for maintaining the supporting structures of the pelvic floor [17,25]. Despite data showing that fractional CO 2 laser treatments are useful and minimally invasive alternatives for treating SUI, a consensus regarding its efficacy is lacking due to low quality of the scientific evidence currently available [17,25,26].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy of Fractional CO₂ Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial

2020

View full text Add to dashboard Cite

Background and Objectives Evaluating the efficacy of the fractional CO2 laser, promestriene, and vaginal lubricant to treat urinary symptoms in women with genitourinary syndrome of menopause. Study Design/Materials and Methods We conducted a randomized clinical trial with 72 postmenopausal women aged 50 years or older. The participants were randomized to one intervention each in three treatment groups fractional CO2 laser, promestriene, and vaginal lubricant. Urinary symptoms were assessed prior to treatment and 2 weeks after treatment completion using validated questionnaires, the International Consultation on Incontinence Questionnaire (ICIQ‐UI SF), and the International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ‐OAB). Results There was a significant reduction in the total ICIQ‐UI SF score in the intragroup comparison (baseline vs. week 14) of the CO2 laser group (P = 0.004). This group also showed a statistically significant reduction in nocturia (1.33 ± 0.87 vs. 1.00 ± 0.76, respectively; P = 0.031). In the intergroup comparison after treatment, nocturia in the lubricant group had worsened compared with that of the other two groups (P = 0.002). Regarding the total ICIQ‐OAB score, the results of the CO2 laser group were superior to those of the lubricant group in the intergroup comparison (7.76 ± 3.36, P = 0.020; analysis of variance P = 0.038). Conclusion The results were significantly different between the intravaginal fractional CO2 laser and topical estrogen groups for treating urinary symptoms related to the genitourinary syndrome of menopause. Further controlled and randomized studies are needed. Lasers Surg. Med. © 2020 Wiley Periodicals, Inc.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Introductionmentioning

confidence: 99%

Efficacy of Fractional CO₂ Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial

2020

View full text Add to dashboard Cite

show abstract

“…A shortcoming of the treatment is that it is effective only for a few years [8–10]. However, to our knowledge, there are no comparative studies on the TVT and TOT procedures [11]. Furthermore, there are no reports on Japanese women.…”

Section: Introductionmentioning

confidence: 99%

Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence

Okui¹

2018

World J Urol

View full text Add to dashboard Cite

show abstract

“…The photothermal effects lead to collagen remodeling and stimulates neocollagenesis, thus strengthening an important component of pelvic floor supportive structures. Indeed, biopsy studies after Er: YAG laser exposure demonstrate improvement in pelvic muscle tissue thickness and structure as well as increased vascularization, as well as SUI symptoms in pre-and postmenopausal women [7,[20][21][22].…”

Section: Laser Therapymentioning

confidence: 99%

“…Stress urinary incontinence typically occurs as the result of weakened pelvic floor muscles that impair the ability of the urethral sphincter to completely close, leading to urine loss at lower-than-normal abdominal pressure. The nerves that control the pelvic floor may also be damaged, while the collagen-dependent connective tissues that provide pelvic support may be weakened [6,7]. Risk factors for SUI include obesity, menopausal status, parity, vaginal delivery, pelvic floor disorders, gynecological surgery, smoking, diabetes, and physical and sexual activity [8].…”

Section: Introductionmentioning

confidence: 99%

Treatment of Female Stress Urinary Incontinence with Hybrid Fractional Laser, Preliminary Study

Schanz¹

2018

JGWH

View full text Add to dashboard Cite

Background: Stress urinary incontinence (SUI) is the involuntary loss of urine during activities requiring increased abdominal activation such as sneezing, coughing, jumping, physical exercise and sports. Despite its prevalence, SUI remains underdiagnosed and undertreated. Current lifestyle and physical therapy treatments have limited success, while surgical options carry with them the risk of significant adverse effects. In recent years, the use of the Er: YAG laser treatment has demonstrated efficacy in alleviating SUI symptoms with minimal adverse effects. A new hybrid fractional laser that enables delivery of both ablative 2940 nm and non-ablative 1470 nm wavelengths, either independently or blended, was recently introduced. This study evaluated its safety and efficacy in SUI.Aim: To determine the knowledge, attitudes and practices of postpatum women with respect to cervical cancer in the health districts of Maroua, northern Cameroon. Methods:We enrolled 19 women with mild-to-severe SUI in this open-label, non-randomized, prospective pilot trial. Inclusion criteria were mild-to-severe SUI, the ability to complete the Consultation on Incontinence Modular Questionnaire Short Form (ICIQ-SF), and the ability to provide voluntary written consent. The degree of SUI and its impact on quality of life was assessed using the ICIQ-UI SF administered at baseline and again 3 months after treatment. Improvement was defined as an ICIQ-SF score lower than baseline regardless of severity stage. The hybrid fractional laser (diVa, Sciton Inc, Palo Alto, CA) was used with ablative 2940nm and non-ablative 1470nm laser wavelengths in an outpatient setting. One treatment pass delivered in 360 degrees circumference to vaginal canal and second pass to anterior vaginal wall was performed. Result:The mean score on the ICIQ-UI at baseline was 12.7 (8-20 range). At 3 months follow-up, the ICIQ-UI mean score was 4.7 (0-14), a 68.4% improvement (p<0.05). Five participants (26.3%) demonstrated a 100% improvement. One patient had a higher ICIQ SF score at 3 months and worsening of symptoms at 3 months. There were no adverse effects, pain, or discomfort reported. Discussion:The results of this pilot study demonstrate that a single treatment with a hybrid fractional laser can improve symptoms of SUI based on the ICIQ-UI with no adverse effects. Treatment was well tolerated. We will report the results after a second treatment session.

show abstract

Laser procedure for female urinary stress incontinence: A review of the literature

Cited by 21 publications

References 24 publications

Efficacy of Fractional CO₂ Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial

Efficacy of Fractional CO₂ Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial

Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence

Treatment of Female Stress Urinary Incontinence with Hybrid Fractional Laser, Preliminary Study

Contact Info

Product

Resources

About

Laser procedure for female urinary stress incontinence: A review of the literature

Cited by 21 publications

References 24 publications

Efficacy of Fractional CO2 Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial

Efficacy of Fractional CO2 Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial

Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence

Treatment of Female Stress Urinary Incontinence with Hybrid Fractional Laser, Preliminary Study

Contact Info

Product

Resources

About

Efficacy of Fractional CO₂ Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial

Efficacy of Fractional CO₂ Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial